Dr. Eric Donald Langewisch, MD

Dr. Langewisch practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Langewisch's NPI, 1366576662, was assigned on March 16, 2007. Dr. Langewisch graduated from University of Iowa, RJ & L Carver College of Medicine in 2001. Dr. Langewisch holds Nebraska license 29332.

Dr. Langewisch's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Langewisch also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Langewisch's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Langewisch to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Langewisch practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Langewisch's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Langewisch is licensed in Nebraska.

CMS data shows 310 Medicare services from Dr. Langewisch across 6 procedure codes in 2024, for 128 Medicare patients. Medicare paid $26,956 for them.

CMS counts 128 Medicare patients who saw Dr. Langewisch in 2024. The largest group is under 65, with 52 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 6.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Langewisch's median patient age at 62, with 46% women.

In 2024, Dr. Langewisch wrote 1,418 Medicare Part D claims for 300 patients. 95% of them were for generic drugs. CMS names the drug for 1,249 of them, across 28 drugs with 11 or more claims each, at $49,374 in total drug cost. In 2023, CMS named 1,671 claims across 35 drugs.

Dr. Langewisch accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Langewisch, published from 2010 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Kidney Transplantation, Tissue Donors and BK Virus. Dr. Langewisch has published most often in Clin J Am Soc Nephrol. Dr. Langewisch's most frequent co-authors are Scott Gregory Westphal, MD, Clifford D. Miles, MD and Shaheed Merani, FRCSC, MD, PhD.

Dmand AI links Dr. Langewisch to 2 clinical trials. 1 is still active or recruiting.

CMS Open Payments shows 24 general payments to Dr. Langewisch from 6 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 53% of the total. CSL Behring paid the most, $2,465.

Dr. Langewisch graduated from University of Iowa, RJ & L Carver College of Medicine in 2001.